NEURON BIO, S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | -.--% |
| 2017 | Neuron BioLabs, S.L. cancelled the acquisition of diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA. | CI |
| 2017 | Neol Biosolutions Seeks Investors | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEURON BIO, S.A. | Bio Therapeutic Drugs | -.--% | -.--% | - | - | - | 5.19M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- NEU Stock
- Charts Neuron Bio, S.A.
- Comparison Chart
